MedicalSentry

Health Research Company

NAPRELAN

generic name is naproxen sodium

Why is this drug subscribed ?

Prescription naproxen is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused by swelling of the lining of the joints), juvenile arthritis (a form of joint disease in children), and ankylosing spondylitis (arthritis that mainly affects the spine). Prescription naproxen tablets, extended-release tablets, and suspension are also used to relieve shoulder pain caused by bursitis (inflammation of a fluid-filled sac in the shoulder joint), tendinitis (inflammation of the tissue that connects muscle to bone), gouty arthritis (attacks of joint pain caused by a build-up of certain substances in the joints), and pain from other causes, including menstrual pain (pain that happens before or during a menstrual period). Nonprescription naproxen is used to reduce fever and to relieve mild pain from headaches, muscle aches, arthritis, menstrual periods, the common cold, toothaches, and backaches. Naproxen is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.

Active Substance: NAPROXEN SODIUM

NAPRELAN Available Drugs :

NAPRELAN ndc# 43063-242

by PD-Rx Pharmaceuticals, Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 750 mg/1

started marketing at 19/12/2008 .

NAPRELAN ndc# 63629-4146

by Bryant Ranch Prepack

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 375 mg/1

started marketing at 05/01/1996 .

NAPRELAN ndc# 21695-906

by Rebel Distributors Corp

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 500 mg/1

started marketing at 05/01/1996 .

NAPRELAN ndc# 21695-905

by Rebel Distributors Corp

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 375 mg/1

started marketing at 05/01/1996 .

NAPRELAN ndc# 35356-530

by Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 500 mg/1

started marketing at 29/11/2011 .

NAPRELAN ndc# 68453-777

by Victory Pharma, Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 750 mg/1

started marketing at 19/12/2008 .

NAPRELAN ndc# 68453-850

by Victory Pharma, Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 500 mg/1

started marketing at 05/01/1996 .

Naprelan ndc# 59630-375

by Shionogi Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 375 mg/1

started marketing at 01/04/1996 .

NAPRELAN ndc# 68453-900

by Victory Pharma, Inc.

ORAL KIT with active strength of

started marketing at 15/10/2009 .

NAPRELAN ndc# 68453-375

by Victory Pharma, Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 375 mg/1

started marketing at 05/01/1996 .

Naprelan ndc# 59630-777

by Shionogi Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 750 mg/1

started marketing at 01/04/1996 .

Naprelan ndc# 59630-850

by Shionogi Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 500 mg/1

started marketing at 01/04/1996 .

NAPRELAN ndc# 16590-242

by STAT RX USA

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 750 mg/1

started marketing at 19/12/2008 .

NAPRELAN ndc# 54868-3974

by Physicians Total Care, Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 375 mg/1

started marketing at 19/08/2005 .

NAPRELAN Search Trends:

News :

Social Buzz

comments powered by Disqus